Mangione pleads guilty to killing UnitedHealthcare CEO
Luigi Mangione, 28, pleaded guilty in Manhattan federal court on Friday to killing UnitedHealthcare CEO Brian Thompson on December 4, 2024.

Stock photo for illustration only, not from the actual event
- Luigi Mangione, 28, pleaded guilty in Manhattan federal court
- Admitted to federal interstate stalking resulting in death
- Killed UnitedHealthcare CEO Brian Thompson on December 4, 2024
- Faces a maximum sentence of life in prison with sentencing on Dec 18
Luigi Mangione, a 28-year-old man, appeared in a Manhattan federal court on Friday to enter a guilty plea regarding the fatal shooting of UnitedHealthcare CEO Brian Thompson. The high-profile incident occurred on December 4, 2024, when the 50-year-old father of two was shot from behind while entering a midtown Manhattan hotel.
During Friday's hearing, Mangione, wearing a beige prison uniform and appearing solemn, read a statement admitting that he planned the attack in advance, crossed state lines with lethal intent, and used a 3D-printed firearm equipped with a silencer and a magazine.
He informed the court that his actions were driven by frustrations with the healthcare system after enduring severe back pain for years. Having learned that UnitedHealthcare would host an annual investor conference in Manhattan in December 2024, he traveled to New York and previously emailed the company posing as an investor to gather information about the event.

Stock photo for illustration only, not from the actual event
"I shot Mr Thompson in Manhattan and he died"
Luigi Mangione
Thompson's family released a statement calling the plea an important step toward justice, noting that while nothing can ease their pain, they are grateful the federal system held the perpetrator accountable. Prosecutors have recommended a prison sentence of 24 to 30 years, though Judge Margaret Garnett emphasized that she makes the final decision. The maximum possible sentence is life in prison without parole, alongside financial penalties, with sentencing scheduled for December 18.
This high-profile case highlights deep-seated public frustrations regarding healthcare access and corporate insurance practices in the United States. Furthermore, the use of a 3D-printed weapon underscores modern regulatory challenges concerning homemade firearms and advancements in accessible manufacturing technology.
Mangione's federal guilty plea could complicate his upcoming New York state trial, which was slated to begin in September across eight state charges including second-degree murder and weapons possession. His defense attorneys argued outside the court that proceeding with the state trial would violate double jeopardy protections, as he has already accepted full responsibility in federal court. However, the Manhattan District Attorney's office stated it remains prepared to continue the state prosecution.
Source: BBC World
Found something wrong in this article? Report an issue with this article
Comments
Leave a Comment